Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
EPHEDRINE SULFATE (EPHEDRINE SULFATE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
EPHEDRINE SULFATE
ANDA
Get alerts
EPHEDRINE SULFATE | A218271 | FRESENIUS KABI USA LLC
2 strengths
0 unique patents
1 unique exclusivity
Reference Listed Drug:
EPHEDRINE SULFATE
(TE code: AP2)
Patents
SEC Intel
Revenue
DMF
Label
Products
Patent Timeline
0 unique patents, 1 exclusivity by expiration date
All strengths
25MG/5ML (5MG/ML)
50MG/10ML (5MG/ML)
Today
Exclusivity
Today
PC
Feb. 21, 2026
Products (2)
Sort:
Name
↑
Applicant
Strength
Approval
#001 — 25MG/5ML (5MG/ML)
AP2
0 patents
1 exclusivity
▴
SOLUTION;INTRAVENOUS | Approved: Mar 11, 2025
Exclusivities (1)
Code
Date
Status
PC
Feb 21, 2026
Expired
#002 — 50MG/10ML (5MG/ML)
AP2
0 patents
1 exclusivity
▾
SOLUTION;INTRAVENOUS | Approved: Mar 11, 2025